Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PERINDOPRIL ERBUMINE vs PERTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PERINDOPRIL ERBUMINE vs PERTUZUMAB: Safety Overview

Metric PERINDOPRIL ERBUMINE PERTUZUMAB
Total FAERS Reports 1,200 21,995
Deaths Reported 97 2,161
Death Rate 8.1% 9.8%
Hospitalizations 621 7,803
Average Patient Age 65.1 yrs 55.8 yrs
% Female Patients 58.1% 95.9%
FDA Approval Date Aug 30, 2010 N/A
Manufacturer Aurobindo Pharma Limited Genentech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription